Abstract:Abstract Background Terpenoids are of high interest as chemical building blocks and pharmaceuticals. In microbes, terpenoids can be synthesized via the methylerythritol phosphate (MEP) or mevalonate (MVA) pathways. Although the MEP pathway has a higher theoretical yield, metabolic engineering has met with little success because the regulation of the pathway is poorly understood. Results We applied metabolic control analysis to the MEP pathway in Escherichia coli expressing a heterologous isoprene synthase gene ( isp S). The expression of isp S led to the accumulation of isopentenyl pyrophosphate (IPP)/dimethylallyl pyrophosphate (DMAPP) and severely impaired bacterial growth, but the coexpression of isp S and isopentenyl diphosphate isomerase ( idi ) restored normal growth and wild-type IPP/DMAPP levels. Targeted proteomics and metabolomics analysis provided a quantitative description of the pathway, which was perturbed by randomizing the ribosome binding site in the gene encoding 1-deoxyxylulose 5-phosphate synthase (Dxs). Dxs has a flux control coefficient of 0.35 (i.e., a 1% increase in Dxs activity resulted in a 0.35% increase in pathway flux) in the isoprene-producing strain and therefore exerted significant control over the flux though the MEP pathway. At higher dxs expression levels, the intracellular concentration of 2- C -methyl- d -erythritol-2,4-cyclopyrophosphate (MEcPP) increased substantially in contrast to the other MEP pathway intermediates, which were linearly dependent on the abundance of Dxs. This indicates that 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase (IspG), which consumes MEcPP, became saturated and therefore limited the flux towards isoprene. The higher intracellular concentrations of MEcPP led to the efflux of this intermediate into the growth medium. Discussion These findings show the importance of Dxs, Idi and IspG and metabolite export for metabolic engineering of the MEP pathway and will facilitate further approaches for the microbial production of valuable isoprenoids.

Development of isopentenyl phosphate kinases and their application in terpenoid biosynthesis

Advances on the Plant Terpenoid Isoprenoid Biosynthetic Pathway and Its Key Enzymes

Biosynthetic studies on terpenoids produced by Streptomyces

Expanding the isoprenoid building block repertoire with an IPP methyltransferase from Streptomyces monomycini.

Current development in isoprenoid precursor biosynthesis and regulation.

Biosynthetic Pathway and Applications of Plant Terpenoid Isoprenoid

Engineering a universal and efficient platform for terpenoid synthesis in yeast

Contribution of isopentenyl phosphate to plant terpenoid metabolism

Yeast Metabolism Adaptation for Efficient Terpenoids Synthesis Via Isopentenol Utilization

Advances in Metabolic Engineering of Saccharomyces Cerevisiae for Terpenoids Biosynthesis

Production of Terpenoids by Synthetic Biology Approaches

Cytochrome P450s in plant terpenoid biosynthesis: discovery, characterization and metabolic engineering

Metabolic engineering and synthetic biology approaches driving isoprenoid production in Escherichia coli

Investigation of the methylerythritol 4-phosphate pathway for microbial terpenoid production through metabolic control analysis

Terpenoids: Opportunities for Biosynthesis of Natural Product Drugs Using Engineered Microorganisms

Combinatorial Pathway Optimization in Escherichia Coli by Directed Co‐evolution of Rate‐limiting Enzymes and Modular Pathway Engineering

Efforts Toward Industrial Biosynthesis of Isoprene

[Enzyme engineering in microbial biosynthesis of terpenoids: progress and perspectives].

Strategies for terpenoid overproduction and new terpenoid discovery.

High Versatility of IPP and DMAPP Methyltransferases Enables Synthesis of C6, C7 and C8 Terpenoid Building Blocks

Metabolic engineering of Yarrowia lipolytica for terpenoids production: advances and perspectives